[Resecting hematogenous metastases: reasons against]

F C Roos1, J W Thüroff

  • 1Urologische Klinik und Poliklinik, Universitätsmedizin, Johannes Gutenberg Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland, frederik.roos@unimedizin-mainz.de.

Summary

Resecting metastases from urological cancers can improve survival, but patient selection is crucial. Current evidence does not support resecting prostate cancer metastases.